Star Therapeutics · 7 hours ago
Part-TIme Clinical QA Contractor
South San Francisco, CA
Part-time, Contract
Hybrid
Senior LevelStar Therapeutics is focused on clinical development programs, and they are seeking a Clinical Quality Assurance Contractor to lead and oversee quality assurance activities. This role will provide strategic and operational QA leadership across clinical trials, ensuring compliance with global regulations and internal quality standards.
Health CareMedicalTherapeutics
Responsibilities
Lead and oversee quality assurance activities related to clinical development programs
Ensure compliance with applicable global regulations (FDA, EMA, ICH, GCP) and internal quality standards
Provide strategic and operational QA leadership across clinical trials, vendors, and internal stakeholders
Support the successful execution of clinical programs from early-phase through late-stage development
Serve as a key quality partner to Clinical Operations, Regulatory Affairs, Pharmacovigilance, and external vendors
Ensure inspection readiness, data integrity, and continuous improvement of the Clinical Quality Management System (CQMS)
Qualification
Required
Lead and oversee quality assurance activities related to clinical development programs
Ensure compliance with applicable global regulations (FDA, EMA, ICH, GCP) and internal quality standards
Provide strategic and operational QA leadership across clinical trials, vendors, and internal stakeholders
Support the successful execution of clinical programs from early-phase through late-stage development
Serve as a key quality partner to Clinical Operations, Regulatory Affairs, Pharmacovigilance, and external vendors
Ensure inspection readiness, data integrity, and continuous improvement of the Clinical Quality Management System (CQMS)
Part-time, contract role, up to 20 hours per week
Onsite, Hybrid or Remote
Company
Star Therapeutics
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Founded in 2018
11-50 employees
Funding
Current Stage
Late StageTotal Funding
$315MKey Investors
Sofinnova Investments
2025-09-30Series D· $125M
2023-09-05Series C· $90M
2022-02-16Series Unknown· $100M
Leadership Team
Adam Rosenthal
CEO & Founder
Scott Robertson
Chief Business Officer and Chief Financial Officer
Recent News
2025-12-11
Company data provided by crunchbase